TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15207987

Group type: EXPERIMENTAL
Intervention: Brief educational intervention and an estimate of breast cancer risk over the telephone
Number of subjects: 392

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 392
Study: 11405514

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (30 mg x day(-1))
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9514183

Group type: EXPERIMENTAL
Intervention: MO/HCTZ 3.75/6.25 mg once daily
Number of subjects: 223

Group type: COMPARATOR
Intervention: PBO
Number of subjects: 223
Study: 9050476

Group type: EXPERIMENTAL
Intervention: Loop electrosurgical conization
Number of subjects: 98

Group type: COMPARATOR
Intervention: Cold knife conization
Number of subjects: 98
Study: 3168445

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Amenorrheic cases
Number of subjects: 236
Study: 30137242

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate/emtricitabine plus atazanavir/ritonavir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Protease inhibitor-based regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline I-FABP levels
Number of subjects: 0
Study: 29251457

Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste plus 3.0% KNO3 mouthwash
Number of subjects: 135

Group type: COMPARATOR
Intervention: Fluoride toothpaste alone
Number of subjects: 135
Study: 25494323

Group type: EXPERIMENTAL
Intervention: Superion interspinous process spacer
Number of subjects: 391

Group type: COMPARATOR
Intervention: Control (X-Stop spacer)
Number of subjects: 391
Study: 24116356

Group type: EXPERIMENTAL
Intervention: MCBA + 5.6 mL of rhBMP‐2/ACS (8.4 mg of rhBMP‐2)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: MCBA + 2.8 mL of rhBMP‐2/ACS (4.2 mg of rhBMP‐2)
Number of subjects: 18

Group type: COMPARATOR
Intervention: MCBA only (control)
Number of subjects: 18
Study: 21951654

Group type: EXPERIMENTAL
Intervention: Single intraarticular injection of 40 mg triamcinolone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Two injections of 40 mg triamcinolone at 21‐day interval
Number of subjects: 60
Study: 19469115

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA) with 10 mL of 0.5% bupivacaine before and at the end of surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thoracic paravertebral analgesia (TPVA) with 30 mL of 0.5% bupivacaine before and 15 mL at the end of surgery
Number of subjects: 60
Study: 17545082

Group type: EXPERIMENTAL
Intervention: Podophyllotoxin solid lipid nanoparticle gel
Number of subjects: 97

Group type: COMPARATOR
Intervention: Routine podophyllotoxin gel preparation
Number of subjects: 97
Study: 12841414

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 10699477

Group type: EXPERIMENTAL
Intervention: 33x2 Gy
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: 8x5 Gy
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: 4x7 Gy
Number of subjects: 155

Group type: COMPARATOR
Intervention: Conventional fractionation up to 66 Gy
Number of subjects: 155
Study: 9373099

Group type: EXPERIMENTAL
Intervention: Immediate indirect laser photocoagulation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 19
Study: 8468105

Group type: EXPERIMENTAL
Intervention: Carleton Skill Training Program (CSTP) to increase hypnotic susceptibility
Number of subjects: 27

Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Carleton Skill Training Program (CSTP)
Number of subjects: 27
Study: 3514908

Group type: EXPERIMENTAL
Intervention: Butoconazole vaginal suppositories, 100 mg/day
Number of subjects: 185

Group type: COMPARATOR
Intervention: Clotrimazole vaginal tablets, 200 mg/day
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 185
Study: 31996717

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 161
Study: 29581967

Group type: EXPERIMENTAL
Intervention: Simple Muscle Strength Test (SMST) - Leg muscle strength
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Simple Muscle Strength Test (SMST) - Back muscle strength
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Simple Muscle Strength Test (SMST) - Sit-ups
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Simple Muscle Strength Test (SMST) - Hand grip
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Simple Muscle Strength Test (SMST) - Standing long jump
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Simple Muscle Strength Test (SMST) - Knee bent push-up
Number of subjects: 240
Study: 27079965

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 200 IU
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 800 IU
Number of subjects: 100
Study: 24882205

Group type: EXPERIMENTAL
Intervention: Standard care plus DVD
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (Standard care and Standard care plus DVD)
Number of subjects: 40
Study: 22422735

Group type: EXPERIMENTAL
Intervention: Left Radial Approach (LRA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Right Radial Approach (RRA)
Number of subjects: 100
Study: 20435293

Group type: EXPERIMENTAL
Intervention: 25 mg of dexketoprofen
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 5 mL intrauterine 2% lidocaine
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 111

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 111
Study: 19115153

Group type: EXPERIMENTAL
Intervention: Alverine citrate plus simethicone (60 mg alverine citrate + 300 mg simethicone)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Alverine citrate plus simethicone
Number of subjects: 165
Study: 15861257

Group type: COMPARATOR
Intervention: Treadmill electrocardiographic stress testing (EST)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Treadmill echocardiographic stress testing (ExE)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography (DSE)
Number of subjects: 158
Study: 12364840

Group type: EXPERIMENTAL
Intervention: Attachment-based family therapy (ABFT) for 12 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Waitlist control group for 6 weeks
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Follow-up assessment of ABFT
Number of subjects: 32
Study: 10472854

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 0.025 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 0.05 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 0.06 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 0.1 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8752759

Group type: EXPERIMENTAL
Intervention: Inhalation of pure oxygen (O2) during EIS
Number of subjects: 50

Group type: COMPARATOR
Intervention: No inhalation of pure oxygen (O2) during EIS
Number of subjects: 50
Study: 1875807

Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Iron and folic acid supplementation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: No supplementation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no blood collection)
Number of subjects: 60
Study: 6401230

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (0.8 mg sublingually)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nifedipine (5 ng/kg/min i.v.)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Metoprolol (0.15 mg/kg i.v.)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 16
Study: 31362561

Group type: EXPERIMENTAL
Intervention: Kinematic alignment using patient-specific instrumentation (KA+PSI)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Mechanical alignment using computer-assisted surgery (MA+CAS)
Number of subjects: 47
Study: 29088437

Group type: EXPERIMENTAL
Intervention: SOLAS intervention training
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: SOLAS intervention delivery
Number of subjects: 13
Study: 26773321

Group type: EXPERIMENTAL
Intervention: Homeopathic complex (6cH each of Arnica montana, Bryonia alba, Causticum, Kalmia latifolia, Rhus toxicodendron, and Calcarea fluorica) plus standard physiotherapy (massage, thermal therapy, joint mobilization) every 2 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo plus standard physiotherapy (massage, thermal therapy, joint mobilization) every 2 weeks
Number of subjects: 30
Study: 24589127

Group type: EXPERIMENTAL
Intervention: Liraglutide plus insulin (LIRA)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Intensive insulin only (controls)
Number of subjects: 37
Study: 22732458

Group type: EXPERIMENTAL
Intervention: Repeated exposure to three vegetables served at lunch on 10 separate occasions (30 days of exposure) in Preschool A.
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Peer eating behaviors (greater consumption by tablemates).
Number of subjects: 96

Group type: COMPARATOR
Intervention: Routine practice in Preschool B (control group).
Number of subjects: 96
Study: 20858273

Group type: EXPERIMENTAL
Intervention: Behaviour Change Counselling (BCC) training for clinicians
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Non-BCC trained clinicians
Number of subjects: 2000
Study: 17697104

Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 16286057

Group type: EXPERIMENTAL
Intervention: Inhaled zanamivir 10 mg once daily for 14 days
Number of subjects: 494

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 494
Study: 12447551

Group type: EXPERIMENTAL
Intervention: Hepatic resection
Number of subjects: 12

Group type: COMPARATOR
Intervention: Gastrectomy (Control)
Number of subjects: 12
Study: 10087688

Group type: EXPERIMENTAL
Intervention: Adolescent group CBT (16 two-hour sessions)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Adolescent group CBT with a separate parent group
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Assessments every 4 months with booster sessions
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Assessments only every 4 months
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Assessments only every 12 months
Number of subjects: 123

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 123
Study: 7491655

Group type: EXPERIMENTAL
Intervention: Acetazolamide (ACZ) 1 to 1.6 g intravenously
Number of subjects: 48
Study: 1968731

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion (0.05 microgram/kg body weight/minute for 120 minutes) with placebo pretreatment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion with atenolol pretreatment (beta-1-selective blocker)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion with propranolol pretreatment (nonselective beta blocker)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion with ICI 118551 pretreatment (beta-2-selective blocker)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Adrenaline infusion with different pretreatments
Number of subjects: 12
Study: 387542

Group type: EXPERIMENTAL
Intervention: Vincristine, methotrexate, cyclophosphamide, and 5-fluorouracil (initiation course) followed by mitomycin-C with 5-fluorouracil (maintenance therapy)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 76
Study: 30082892

Group type: EXPERIMENTAL
Intervention: Oxytocin 36 IU
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Oxytocin 48 IU
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 28109324

Group type: EXPERIMENTAL
Intervention: Pre-CONSORT period
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Post-CONSORT period
Number of subjects: 351
Study: 26155878

Group type: EXPERIMENTAL
Intervention: Behavioral intervention technologies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 23143991

Group type: EXPERIMENTAL
Intervention: Hypoxia
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isocapnic hypoxia (12% O2; controlled gas mixture)
Number of subjects: 10
Study: 22221684

Group type: EXPERIMENTAL
Intervention: IAADS (Improved Anesthetic Agent Delivery System)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual control (Tech 7 vaporizer)
Number of subjects: 40
Study: 19419356

Group type: EXPERIMENTAL
Intervention: Infraclavicular block
Number of subjects: 120

Group type: COMPARATOR
Intervention: Supraclavicular block
Number of subjects: 120
Study: 16426267

Group type: EXPERIMENTAL
Intervention: Migraine patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster headache patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 0
Study: 15474248

Group type: EXPERIMENTAL
Intervention: Vitamin C vaginal tablets (250 mg) once a day for 6 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vitamin C vaginal tablets
Number of subjects: 100
Study: 14607676

Group type: EXPERIMENTAL
Intervention: Combined transjugular intrahepatic portosystemic shunt (TIPS) and modified Sugiura
Number of subjects: 20

Group type: COMPARATOR
Intervention: Modified Sugiura only
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (20 healthy subjects)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Modified Sugiura (after TIPS in group A)
Number of subjects: 20
Study: 9565942

Group type: EXPERIMENTAL
Intervention: 6% CHO drink
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 8% CHO drink
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Most liked fluid
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Least liked fluid
Number of subjects: 15
Study: 7645388

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sodium Valproate (SV)
Number of subjects: 27
Study: 2787809

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 150 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin 2600 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cimetidine and antacids (added after severe injuries)
Number of subjects: 0
Study: 557318

Group type: EXPERIMENTAL
Intervention: 0.8 mg subcutaneous physostigmine therapy (three sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control injections (randomly interspersed sessions)
Number of subjects: 0
Study: 31818516

Group type: EXPERIMENTAL
Intervention: Purple potato extract (PPE)
Number of subjects: 17
Study: 31699568

Group type: EXPERIMENTAL
Intervention: hs-CRP levels
Number of subjects: 1734

Group type: EXPERIMENTAL
Intervention: hs-CRP ≥0.74 mg/L at 3 months
Number of subjects: 1734
Study: 27459721

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 25497995

Group type: EXPERIMENTAL
Intervention: Omalizumab (225-300 mg every 2 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omalizumab (every 4 weeks dosing regimen)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omalizumab (higher or lower doses)
Number of subjects: 0
Study: 23482056

Group type: EXPERIMENTAL
Intervention: 70,000 IU once + 35,000 IU/week vitamin D3 (group PH)
Number of subjects: 28

Group type: COMPARATOR
Intervention: 14,000 IU/week vitamin D3 (PL)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 70,000 IU once + 35,000 IU/week vitamin D3 (NH)
Number of subjects: 28
Study: 25427325

Group type: EXPERIMENTAL
Intervention: 0.1% chlorhexidine mouthwash for 2 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.1% chlorhexidine mouthwash with subgingival irrigation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.1% chlorhexidine mouthwash
Number of subjects: 60
Study: 18534685

Group type: EXPERIMENTAL
Intervention: Patients with somatic delusions
Number of subjects: 183

Group type: COMPARATOR
Intervention: Patients without somatic delusions
Number of subjects: 183
Study: 17351987

Group type: EXPERIMENTAL
Intervention: Anthroposophy art therapy (painting with water-based paints)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (participants with < or =2 sessions)
Number of subjects: 60
Study: 15353002

Group type: COMPARATOR
Intervention: 15 g alcohol per day
Number of subjects: 51

Group type: COMPARATOR
Intervention: 30 g alcohol per day
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 51
Study: 11294662

Group type: EXPERIMENTAL
Intervention: Indinavir, zidovudine, and lamivudine
Number of subjects: 28
Study: 9625847

Group type: EXPERIMENTAL
Intervention: Collecting duct carcinomas (CDC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clear cell renal cell carcinoma (cRCC)
Number of subjects: 0
Study: 29374350

Group type: EXPERIMENTAL
Intervention: Nefopam (20 mg mixed in 100 ml normal saline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (100 ml normal saline only)
Number of subjects: 60
Study: 28732531

Group type: EXPERIMENTAL
Intervention: Endometrial scratching in the luteal phase prior to controlled ovarian hyperstimulation
Number of subjects: 900

Group type: COMPARATOR
Intervention: Control group (no endometrial scratching)
Number of subjects: 900
Study: 26287351

Group type: EXPERIMENTAL
Intervention: Heated humidified high-flow nasal cannula (HHHFNC)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (NCPAP)
Number of subjects: 66
Study: 23007732

Group type: EXPERIMENTAL
Intervention: Radiofrequency-assisted parenchyma transection (RF-PT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Clamp-crushing parenchyma transection (CC-PT)
Number of subjects: 75
Study: 19172293

Group type: EXPERIMENTAL
Intervention: FIGO grading system
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: GOG grading system
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Silverberg grading system
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Concordance rates between grading systems
Number of subjects: 334
Study: 17784972

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) administered over six weekly sessions
Number of subjects: 22

Group type: COMPARATOR
Intervention: Delayed cognitive-behavioural therapy (D-CBT) administered twice weekly over three weeks
Number of subjects: 22
Study: 14996630

Group type: EXPERIMENTAL
Intervention: Platelet glycoprotein IIb/IIIa inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral antiplatelet and antithrombotic therapies
Number of subjects: 0
Study: 12056242

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy using five different protocols
Number of subjects: 731
Study: 9931764

Group type: COMPARATOR
Intervention: Electrostimulation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biofeedback training
Number of subjects: 0
Study: 8081671

Group type: EXPERIMENTAL
Intervention: Blackcurrant seed oil (BCSO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2686259

Group type: EXPERIMENTAL
Intervention: 4 mg/h of ISDN
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 791583

Group type: EXPERIMENTAL
Intervention: clemastine
Number of subjects: 46

Group type: COMPARATOR
Intervention: chlorpheniramine maleate
Number of subjects: 46
Study: 31262673

Group type: EXPERIMENTAL
Intervention: Participation in transition education program
Number of subjects: 123
Study: 27859533

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment-based approach (ART-based)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 127
Study: 25727953

Group type: EXPERIMENTAL
Intervention: 0.5‐h infusion of 0.5 g of imipenem every 6 h for 8 doses
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 4‐h infusion of 0.5 g of imipenem every 6 h for 8 doses
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 4‐h infusion of 1 g of imipenem every 6 h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.5‐h infusion of 1 g of imipenem every 6 h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All simulated regimens (4‐h infusion)
Number of subjects: 10
Study: 23478070

Group type: EXPERIMENTAL
Intervention: Lansoprazole (LPZ) 15mg once daily
Number of subjects: 59

Group type: COMPARATOR
Intervention: Gefarnate (GFN) 50mg twice daily
Number of subjects: 59
Study: 21673035

Group type: EXPERIMENTAL
Intervention: Early BCG vaccination at birth
Number of subjects: 2320
Study: 19317378

Group type: EXPERIMENTAL
Intervention: Ramelteon 8 mg at bedtime for 10 weeks
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ramelteon 8 mg at bedtime
Number of subjects: 27
Study: 17162041

Group type: EXPERIMENTAL
Intervention: Pelvicol porcine collagen implant
Number of subjects: 206

Group type: COMPARATOR
Intervention: No implant (control group)
Number of subjects: 206
Study: 15503333

Group type: EXPERIMENTAL
Intervention: Acquisition-weighted 31P-MR spectroscopy (AW-MRS)
Number of subjects: 8
Study: 11522950

Group type: EXPERIMENTAL
Intervention: Gamma-band EEG in autism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gamma-band EEG in Williams syndrome
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of autism and Williams syndrome
Number of subjects: 0
Study: 9576159

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sotalol
Number of subjects: 70
Study: 7843479

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (elemental calcium 156 or 312 mg/day per os) and vitamin D3 (0.5 micrograms/3 day per os)
Number of subjects: 876
Study: 3279745

Group type: EXPERIMENTAL
Intervention: Milk-based fortified product (V-N)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Powdered milk (PUR)
Number of subjects: 2
Study: 30851939

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 90